Markets › India › NSE › NEULANDLAB

Neuland Laboratories Ltd

NSE:NEULANDLABHealthcareNSE:CNX500NSE:CNXSMALLCAP

₹19,220.00−2.31%At closeAt close · Mon 19 Oct · ≈ AED 741.56 · Market cap $2.63B · Next earnings Tue 10 Nov

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	39.6%	40.1%	47.1%	51.6%	47.7%	31.8%	—	—
Operating margin	11.9%	10.4%	20.2%	26.9%	18.6%	23.9%	23.9%	+0.0 pts
Net margin	8.8%	6.9%	14.1%	19.8%	18.1%	18.0%	18.0%	+0.0 pts
EBITDA margin	17.2%	15.2%	24.0%	31.1%	29.1%	29.9%	—	—
Return on equity	10.3%	7.6%	16.4%	23.4%	17.1%	19.4%	19.4%	+0.0 pts
Return on assets	6.1%	4.6%	10.4%	16.4%	11.9%	12.4%	12.4%	+0.0 pts
Return on capital employed	11.5%	9.4%	20.5%	29.0%	15.6%	21.7%	—	—
Debt / equity	0.2×	0.3×	0.1×	0.1×	0.1×	0.2×	0.2×	+0.0%
Debt / assets	13.8%	17.4%	8.1%	5.2%	7.2%	10.3%	—	—
Interest coverage	6.1×	7.1×	17.9×	29.1×	32.1×	20.2×	—	—
Current ratio	1.5×	1.6×	1.7×	2.2×	2.4×	2.1×	2.1×	+0.0%
Quick ratio	0.8×	0.9×	1.1×	1.3×	1.6×	1.4×	—	—
Cash ratio	0.0×	0.0×	0.1×	0.2×	0.3×	0.1×	0.1×	+0.0%
Asset turnover	0.7×	0.7×	0.7×	0.8×	0.7×	0.7×	—	—
Inventory turnover	2.2×	2.1×	2.2×	2.1×	1.9×	2.7×	—	—
Receivables turnover	4.2×	3.9×	3.1×	4.0×	4.5×	3.7×	—	—
Dividend payout	3.2%	6.0%	3.9%	4.3%	6.9%	4.2%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.